Kai-Lung Tsai
Overview
Explore the profile of Kai-Lung Tsai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng L, Su P, Kuo M, Lin C, Luo H, Chou C, et al.
Ther Adv Med Oncol
. 2024 Dec;
16:17588359241305091.
PMID: 39687055
Background: Despite the revolutionary impact of immune checkpoint inhibitors (ICIs) on the treatment of metastatic urothelial carcinoma (mUC), the clinical utility of reliable prognostic biomarkers to foresee survival outcomes remains...
2.
Canseco L, Liu Y, Lu C, Lee K, Chen H, Hu W, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760404
Hepatectomy and/or local ablation therapy have been recommended for colorectal cancer liver metastases (CRLM). However, they still lack strong evidence for their survival benefits, in addition to systemic therapy. This...
3.
Tsai T, Su P, Huang S, Kuo M, Lin C, Wu C, et al.
BMC Cancer
. 2023 Sep;
23(1):871.
PMID: 37715113
Background: While the treatment guidelines have been established for pure urothelial carcinoma (pUC), patients with variant type urothelial carcinoma (vUC) face limited effective treatment options. The effectiveness of immune checkpoint...
4.
Su Y, Tsai K, Chiu T, Lin Y, Lee K, Lu C, et al.
Cancers (Basel)
. 2021 Oct;
13(20).
PMID: 34680230
(1) Background: To investigate the prognostic value of cancer-inflammation prognostic index (CIPI) in patients with metastatic colorectal cancer (mCRC) on regorafenib treatment; (2) Methods: Patients with mCRC who were given...
5.
Ng B, Yu-Li Su H, Tsai K
Am J Gastroenterol
. 2020 Nov;
115(11):1747.
PMID: 33156089
No abstract available.
6.
Liu Y, Lu C, Chang C, Lee K, Chen H, Yeh W, et al.
Sci Rep
. 2020 Apr;
10(1):6459.
PMID: 32296122
The prognostic significance of sarcopenia has been widely studied in different cancer patients. This study aimed to analyze the influence of sarcopenia on long-term survival in patients with colorectal liver...
7.
Kuo M, Hu T, Hung C, Wang J, Lu S, Tsai K, et al.
Aliment Pharmacol Ther
. 2018 Nov;
49(2):218-228.
PMID: 30484881
Background: Entecavir (ETV) and tenofovir disoproxil fumarate (TDF) are first-line long-term monotherapy for treatment of chronic hepatitis B (CHB) infection. High virological relapse rates are found after cessation of either...
8.
Huang P, Tsai K, Liang C, Tai W, Rau K, Wu K, et al.
Kaohsiung J Med Sci
. 2018 Nov;
34(11):650-656.
PMID: 30392572
There is an increasing trend in the incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) worldwide. The aim of the present study was to identify the prognostic factors of patients with GEP-NENs....
9.
Tsai K, Lai W, Lee K, Lin S, Chang C, Lu C, et al.
Biomed Res Int
. 2018 Oct;
2018:9123912.
PMID: 30356463
Background: There are still discrepancies among general/colorectal surgeons regarding closure of mesenteric defect in scientific literature. This study aimed to assess the long-term consequences of nonclosure of the mesenteric defect...
10.
Liang C, Chiu C, Wang H, Tai W, Yao C, Tsai C, et al.
Biomed Res Int
. 2018 Jan;
2017:3762194.
PMID: 29376072
Aims: Patients with chronic kidney disease (CKD) and () infection have a higher incidence of gastroduodenal diseases and therefore are recommended to receive eradication therapies. This study aimed to assess...